Weight | 1 lbs |
---|---|
Dimensions | 9 × 5 × 2 in |
accession | P10720 |
express system | HEK293 |
product tag | C-hFc |
purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
background | Platelet factor-4 (CXCL4/PF-4) was the first chemokine shown to inhibit angiogenesis. CXCL4L1/PF-4var, recently isolated from thrombin-stimulated platelets, differing from authentic CXCL4/PF-4 in three carboxy-terminally located amino acids, was found to be more potent than CXCL4/PF-4 in inhibiting angiogenesis and tumor growth. Both glycosaminoglycans (GAG) and CXCR3 are implicated in the activities of the PF-4 variants. |
molecular weight | The protein has a predicted MW of 35.01 kDa. Due to glycosylation, the protein migrates to 43-48 kDa based on Tris-Bis PAGE result. |
available size | 100 µg, 500 µg |
endotoxin | Less than 1EU per μg by the LAL method. |
Human CXCL4L1 Protein 3202
$240.00 – $800.00
Summary
- Expression: HEK293
- Pure: Yes (HPLC)
- Amino Acid Range: Phe31-Ser104
Human CXCL4L1 Protein 3202
protein |
---|
Size and concentration 100, 500µg and lyophilized |
Form Lyophilized |
Storage Instructions Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
Storage buffer Shipped at ambient temperature. |
Purity > 95% as determined by Tris-Bis PAGE |
target relevance |
---|
Platelet factor-4 (CXCL4/PF-4) was the first chemokine shown to inhibit angiogenesis. CXCL4L1/PF-4var, recently isolated from thrombin-stimulated platelets, differing from authentic CXCL4/PF-4 in three carboxy-terminally located amino acids, was found to be more potent than CXCL4/PF-4 in inhibiting angiogenesis and tumor growth. Both glycosaminoglycans (GAG) and CXCR3 are implicated in the activities of the PF-4 variants. |
Protein names Platelet factor 4 variant (C-X-C motif chemokine 4 variant) (CXCL4L1) (PF4alt) (PF4var1) [Cleaved into: Platelet factor 4 variant(4-74); Platelet factor 4 variant(5-74); Platelet factor 4 variant(6-74)] |
Gene names PF4V1,PF4V1 CXCL4V1 SCYB4V1 |
Protein family Intercrine alpha (chemokine CxC) family |
Mass 9606Da |
Function Inhibitor of angiogenesis. Inhibitor of endothelial cell chemotaxis (in vitro). |
Catalytic activity BINDING 95..101; /ligand="heparin"; /ligand_id="ChEBI:CHEBI:28304" |
Subellular location Secreted. |
Structure Homotetramer. |
Post-translational modification The N-terminal processed forms of platelet factor 4 variant seems to be produced by proteolytic cleavage. The most abundant form is Platelet factor 4 variant(5-74). |
Target Relevance information above includes information from UniProt accession: P10720 |
The UniProt Consortium |
Data
![]() |
The purity of Human CXCL4L1 is greater than 95% as determined by SEC-HPLC. |
![]() |
Human CXCL4L1 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%. |
Publications
Publications
pmid | title | authors | citation |
---|---|---|---|
We haven't added any publications to our database yet. |
Protocols
relevant to this product |
---|
Documents
# | ||
---|---|---|
Please enter your product and batch number here to retrieve product datasheet, SDS, and QC information. |